内镜下游离皮瓣鼻黏膜重建术治疗遗传性出血性毛细血管扩张症
本研究评估内镜下放置游离皮瓣行鼻腔黏膜重建(REFF)治疗遗传性出血性毛细血管扩张症(HHT)相关鼻出血的可行性与疗效。术后一年鼻出血严重程度评分(ESS)从8.9降至3.5,鼻腔功能得以维持,提示REFF对其他治疗无效的HHT相关鼻出血安全有效。
要点
- REFF可显著降低HHT相关鼻出血严重程度,ESS从8.9降至3.5。
- 该术式适用于其他治疗无效的难治性HHT鼻出血。
- 术后鼻腔功能维持,长期鼻出血显著减少。
核心结论
- 内镜下游离皮瓣鼻腔黏膜重建术(REFF)是治疗其他治疗无效的HHT相关鼻出血的安全有效方法。
研究设计与样本
- 评估REFF治疗HHT相关鼻出血可行性与结局的研究,比较术前与术后一年ESS。
主要发现
- 鼻腔成功以前臂桡侧游离皮瓣完成黏膜重建。
- ESS从术前8.9降至术后一年3.5。
- 鼻腔功能维持,长期鼻出血显著减少。
关键数值与推荐
- ESS术前8.9,术后一年3.5。
临床怎么用
- 对于其他治疗无效的难治性HHT相关鼻出血,可考虑REFF以降低出血严重程度并维持鼻腔功能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Epistaxis related to hereditary hemorrhagic telangiectasia (HHT) can be life-threatening and decreases quality of life (QoL). Current medical and surgical options are limited, particularly in the advanced stages of the disease. METHODS: We assess the feasibility and outcome of HHT-related epistaxis management by resurfacing the nasal cavity with an endoscopically placed free flap. The Epistaxis Severity Score (ESS) was compared to the preoperative score at one-year post-surgery. RESULTS: The nasal cavity was successfully resurfaced with a radial forearm free flap. The ESS decreased from 8.9 to 3.5 one-year postoperatively. CONCLUSION: Resurfacing endoscopic free flap (REFF) is a safe and effective procedure for the management of HHT-related epistaxis refractory to other treatment options. Nasal function is maintained, with a significant long-term decrease in epistaxis.
引用
- Haugen TW, Lesh RW, Desiato VM, et al. Resurfacing Endoscopic Free Flap for Hereditary Hemorrhagic Telangiectasia. Head Neck. 2026. PMID: 42252661. doi:10.1002/hed.70341
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。